InflaRx (IFRX) Current Leases (2019 - 2025)
InflaRx (IFRX) posted Current Leases of $299092.8 for Q4 2025, down 33.15% sequentially from $447389.0 in Q2 2025, and down 31.06% YoY from $433871.1 in Q4 2024.
InflaRx (IFRX) Current Leases (2019 - 2025) Analysis & Trends
InflaRx has reported Current Leases for 7 years, with the latest figure at $299092.8 in Q4 2025.
- Quarterly Current Leases fell 31.06% year-over-year to $299092.8 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $299092.8 (down 31.06% YoY) and the FY2025 annual result came in at $290297.1, down 33.94% from the prior year.
- Current Leases eased to $299092.8 in Q4 2025 per IFRX's latest filing, from $447389.0 in the prior quarter.
- Over five years, Current Leases peaked at $429.1 billion in Q3 2021 and troughed at $299092.8 in Q4 2025.
- A 5-year average of $42.9 billion and a median of $410822.2 in 2021 frame the typical range for Current Leases.
- The sharpest annual moves came in 2021 and 2025: Current Leases surged 71700.39% in 2021, then plunged 31.06% in 2025.
- Over 5 years, Current Leases stood at $418889.0 in 2021, then fell by 10.03% to $376854.9 in 2022, then gained by 6.87% to $402755.5 in 2023, then grew by 7.73% to $433871.1 in 2024, then slumped by 31.06% to $299092.8 in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $299092.8, $447389.0, and $433871.1 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | InflaRx | 140.30 Mn | -43.96 Mn | 2.74 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 299,092.83 |
| Jun 30, 2025 | 447,388.96 |
| Dec 31, 2024 | 433,871.10 |
| Jun 30, 2024 | 428,035.89 |
| Dec 31, 2023 | 402,755.51 |
| Jun 30, 2023 | 387,764.89 |
| Dec 31, 2022 | 376,854.89 |
| Jun 30, 2022 | 394,974.23 |
| Dec 31, 2021 | 418,888.99 |
| Sep 30, 2021 | 429.11 Bn |
| Dec 31, 2020 | 403,609.19 |
| Sep 30, 2020 | 597.65 Mn |
| Jun 30, 2020 | 577.20 Mn |
| Mar 31, 2020 | 565.33 Mn |
| Dec 31, 2019 | 570,271.85 |
| Jun 30, 2019 | 380,913.65 |